PetVivo (PETVW) Stock Analysis
NASDAQHealthcareMedical - Devices
What PetVivo does
PetVivo Holdings, Inc. operates as a veterinary biotechnology and biomedical device enterprise, dedicated to the development, strategic licensing, and commercialization of innovative medical instruments and biomaterials. Its mission is to address diverse afflictions and maladies impacting animal health. The company's premier offering is Kush, an injectable solution for joints that veterinarians administer to mitigate the effects of osteoarthritis and mobility impairment in canine and equine patients. Furthermore, PetVivo's future product roadmap encompasses 17 distinct therapeutic devices, poised for both animal and human clinical applications. The firm maintains its corporate headquarters in Minneapolis, Minnesota.
Key metrics
ETFs linked to PETVW
Broad-market and Healthcare sector ETFs an investor holding PetVivo is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how PETVW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze PETVW in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for PetVivo?
- PetVivo trades under the ticker PETVW on NASDAQ.
- Which exchange is PETVW listed on?
- PETVW is listed on NASDAQ.
- What sector does PetVivo operate in?
- PetVivo is classified in the Healthcare sector (Medical - Devices industry).
- How can PortView help analyze PETVW in a portfolio?
- PortView shows PETVW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.